<DOC>
	<DOCNO>NCT01582867</DOCNO>
	<brief_summary>The current study aim assess HemoControl prescription On-Line Hemodiafiltration treatment .</brief_summary>
	<brief_title>HemoControl System Activated Hemodiafiltration Treatments</brief_title>
	<detailed_description>Hemodiafiltration ( HDF ) dialysis technique allow removal high molecular weight toxic solutes exploit convective transport dialyzer membrane : time , HDF positive impact systemic hemodynamic , ameliorate way tolerance treatment . Unfortunately , also HDF therapy well tolerate , introduce patient serious hypovolemia removal body water accumulate interdialytic period . The HemoControl system , automatically control relative blood volume change patient , avoids onset hypovolemia . Today HemoControl system use conventional hemodialysis treatment ; objective study combine advantage intradialytic hemodynamic stabilization achievable mean HemoControl inherent advantage , depurative cardiovascular kind , typical Hemodiafiltration technique .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>A subject must meet ALL follow inclusion criterion order participate study : ESRD chronic dialysis treatment least 3 month Age ≥ 18 year Body weight ≥ 40 kg Blood flow rate ≥ 250 ml/min recirculation vascular access &lt; 5 % Use fraction heparin continuous infusion anticoagulant Stable anticoagulation dosage last 6 treatment Stable dialysis prescription ( Qb , Qd , treatment time ) last 6 treatment Informed consent participate study Stable Haemoglobin concentration begin treatment low equal 14 g/dl . A subject shall NOT participate study he/she meet ANY follow criterion : HIV positivity Active Hepatitis A , B C Pregnancy Participating clinical investigation course study Failed release consent Known coagulation disorder ( clot problem ) Known bleed risk Clinical laboratory diagnosis acute infection Recent ( last 4 week ) surgical intervention Therapy prescribe HD , HF isolate UF mode Active phase cancer , Active phase immune disease . Serious hemostasis disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Hemodiafiltration</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Sodium</keyword>
	<keyword>Artis</keyword>
	<keyword>renal failure</keyword>
</DOC>